Progress on monsoons along with favourable base effect in 2HFY2017 continues to point towards RBI achieving its near 5 per cent inflation target by the year-end
The Sensex took less than two years to rally from the 10,000-mark it first hit in February 2006 to double that on that New Year's Eve.
Markets crashed due to domestic worries; bluechip stocks tanked too.
The rupee fell to a two-year low of 64.84 against the US dollar.
.jpg)
Markets ended lower on profit taking ahead of June F&O expiry.
The idea that technology and startups with newer business models will not disrupt traditional businesses has been thrown out the window.
In the broader market, the BSE Midcap was down 0.2%, while BSE Smallcap fell 0.1%.
Markets extended gains led by financials and capital goods shares coupled with a rebound in IT shares.
ICICI Bank, ONGC and Tata Motors contribute to nearly 50% gain seen on the Nifty.
Major global indices like CAC 40, DAX Shanghai Composite, Hang Seng, Nikkei, Straits Times, Sensex, Nifty have lost 1% - 10% in a week
Capital goods, IT, auto and pharmaceuticals lead gains for the financial year
The 30-share Sensex ended higher by 30 points.
A recovery in rupee, buying by domestic institutional investors, encouraging earnings by select blue-chips and stock specific buying helped the market get back on its feet
The NSE 50-share index, after moving between 10,469.90 and 10,395.25, finally concluded at 10,458.65, up 41.50 points
The BSE Sensex zoomed 318 points to end at 33,351.57, while the broader Nifty spurted 88 points to 10,242.65.
'The IPO window has been more or less open since the new government in 2014.'
Strong gains in Vedanta Ltd, Adani Ports, Bharti Airtel and Maruti Suzuki helped the index touch record levels.
Sensex, Nifty end lower on global concerns.
In last few years, a number of global players have exited the Indian mutual fund business.
Mumbai developers are battling high inventory.
The Sensex ended up 380 points at 27,888 and the Nifty advanced 111 points to end five points shy of 8,400.
Over the past 25 years the MF industry has come a long way. Geographic reach has increased, many more customers have been added, more channels have been opened up and the product basket is full.
Index heavyweights were the top losers along with bank shares.
Sun Pharma dipped 2% to Rs 615 on the BSE, its lowest level since November 9, 2016
State owned banks SBI and PNB were the top Nifty gainers along with ICICI Bank and auto shares.
Most of the session's gains for both the indices were wiped out as investors rushed to book profits ahead of F&O expiry on Thursday and also due to concerns over stretched valuations.
BSE Metal and Capital Goods indices plunged over 2% followed by counters like Consumer Durables, Auto, Banks and Realty, all falling down between 1-2%.
Axis Bank emerged as the biggest gainer in the Sensex pack, surging 6.62 per cent, followed by SBI at 5.88 per cent.
The BSE Midcap and Smallcap indices have performed better than the front-liners
Sun Pharma was by far the biggest gainer in the Sensex pack, surging 8.13 per cent, followed by Dr Reddy's at 4.92 per cent.
.jpg)
The RBI has accepted the application withdrawal request, according to the statement.
The Sensex and the Nifty witnessed biggest one day loss in percentage terms since June 24
Sensex eneded 374 points higher on rate cut expectation from the RBI.
The banking, oil and metal sectors were the top sectoral losers on the BSE, while IT stocks rendered support at lower levels.
Profit taking in index heavweights RIL and HDFC weighed on sentiment while ICICI Bank surged 7%.
The benchmark Nifty rallied 1,000 points or 17% from 7,000 in 78 trading sessions since May 12, till date to surpass the 8,000 mark.
The NSE 50-share Nifty spurted 97.25 points, or 0.92 per cent, to 10,715.50
Among the gainers, Sun Pharma topped by rising 3.03 per cent as the weak rupee tempted buyers to accumulate shares of pharma exporters.
Sensex may remain under pressure this week due to weak global factors.
Based on this screening, the committee may weed out applications that do not meet the eligibility yardstick or the 'fit and proper' criteria for securing a licence.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances